Certara Inc. is a prominent player in the biopharmaceutical industry, specializing in biosimulation and regulatory software to accelerate drug discovery, development, and approval processes. Its prima... Certara Inc. is a prominent player in the biopharmaceutical industry, specializing in biosimulation and regulatory software to accelerate drug discovery, development, and approval processes. Its primary function is to provide advanced technology solutions that streamline the journey of potential therapies from laboratory to market. Certara offers sophisticated modeling and simulation software that assists pharmaceutical companies in predicting drug behavior and efficacy, thereby enhancing decision-making and reducing development costs. Notable features of Certara’s offerings include its comprehensive suite of platforms like Simcyp and Phoenix, which are widely adopted for pharmacokinetic/pharmacodynamic (PK/PD) modeling and clinical trial analysis. The company serves a critical role in the life sciences sector by helping to bring new medicines to patients more efficiently. Certara’s impact is significant as it actively collaborates with major pharmaceutical and biotech companies globally, solidifying its position as a vital contributor to the advancement of healthcare and therapeutic innovation.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Certara is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Certara is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review Certara's data?

Create a free Tracenable account to signal interest in having our team review data for Certara.

Legal Center Contact Us